Statement Of Cash Flows [Abstract]

Alligator Bioscience - Filing #690835

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations before changes in working capital
181 588 SEK
130 587 SEK
Adjustments for decrease (increase) in trade and other receivables
5 859 SEK
13 589 SEK
Adjustments for increase (decrease) in trade and other payables
14 840 SEK
17 144 SEK
Income taxes paid, classified as operating activities
- SEK
- SEK
Cash flows from (used in) financing activities [abstract]
Proceeds from exercise of warrants
426,000 SEK
- SEK
Payments for share issue costs
343,000 SEK
33 897 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.